Direct Tumor Irradiation Potentiates Adoptive NK Cell Targeting Against Parental and Stemlike Cancer in Human Liver Cancer Models

• Published in: International journal of radiation oncology, biology, physics Vol. 119; no. 1; pp. 234 - 250
• Main Authors: Uong, Tung Nguyen Thanh, Yoon, Meesun, Chung, Ik-Joo, Nam, Taek-Keun, Ahn, Sung-Ja, Jeong, Jae-Uk, Song, Ju-Young, Kim, Yong-Hyub, Nguyen, Huy Phuoc Quang, Cho, Duck, Chu, Tan-Huy, Dang, Giang Chau, Nguyen, Nhat Phuoc Nguong Minh
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.05.2024
• Subjects: Animals; Cytotoxicity, Immunologic; Humans; Intercellular Adhesion Molecule-1; Killer Cells, Natural; Liver Neoplasms - metabolism; Lymphocyte Function-Associated Antigen-1 - metabolism; Lymphocyte Function-Associated Antigen-1 - pharmacology; Mice; Parents; Tumor Microenvironment
• ISSN: 0360-3016; 1879-355X
• DOI: 10.1016/j.ijrobp.2023.11.023

Radiation therapy (RT) has been shown to effectively induce the expression of intercellular adhesion molecule-1 (ICAM-1), which is recognized by lymphocyte function-associated antigen 1 (LFA-1) expressed on natural killer (NK) cells. However, the potential synergistic antitumor immune response of tumor irradiation and administered NK cells has not been explored in intractable human liver cancers. Furthermore, NK cell targeting against both parental and cancer stemness has never been investigated. Highly activated ex vivo NK cells were administered into the human liver tumor–bearing mice. Tumor direct RT was optimized according to tumor bearing site. HepG2 and Hep3B ICAM-1 knockout cells were generated using CRISPR/CAS9. Stemness tumor spheres were generated. NK cell cytolysis against parental and tumor sphere was evaluated using flow cytometry and real-time cytotoxicity assay. A combination of adoptive NK cell therapy with RT significantly improved therapeutic efficacy over monotherapies against subcutaneous, orthotopic, and metastatic human liver tumor models. Direct tumor irradiation potentiated NK cell recognition and conjugation against liver cancer through the LFA-1/ICAM-1 axis. Suppression of immune synapse formation on NK cells using high-affinity LFA-1 inhibitors or ICAM-1 knockout liver cancer induced “outside-in” signal blocking in NK cells, resulting in failure to eliminate liver tumor despite the combination therapy. NK cells effectively recognized and targeted triple-high epithelial cell adhesion molecule+CD133+CD24+ liver cancer expressing upregulated ICAM-1 in the irradiated tumor microenvironment, which led to prevention of the initiation of metastasis, improving survival in a metastatic model. In addition, the LFA-1/ICAM-1 axis interruption between NK cells and stemness liver tumor spheres significantly diminished NK cell cytolysis. Consistent with our preclinical data, the LFA-1/ICAM-1 axis correlated with survival outcomes in patients with metastatic cancer from the The Cancer Genome Atlas databases. NK cells in combination with tumor irradiation can provide synergistic therapeutic effects for NK cell recognition and elimination against both parental and stemlike liver cancer through LFA-1/ICAM-1.